
GeneCentric
Durham, NC, United Statesgenecentric.comFrom their website, Nov 2026
Work here? Claim this listing
About
GeneCentric develops gene-expression-based biomarkers and liquid biopsy technologies for precision oncology. It works with biopharma, diagnostics, technology, CRO, and commercial lab partners, with headquarters in Durham, North Carolina. Its products and collaborations focus on extracting expression and subtype information from cfDNA or RNA data.
Services
ExpressCT™ Biopharma Solutions
Gene expression-based products and biomarker development for precision oncology programs.
ExpressCT™ liquid biopsy pipeline
Measures gene expression from sequencing data to support biomarkers across breast cancer subtype, lung histology, pan-cancer prognosis, PDAC molecular subtype, tumor fraction, and tissue of origin.
ExpressCT Rewind™
Analyzes banked CGP or WGS cohort FASTQ files to return expression biomarker results without new samples or a new assay.
Prospective integration of ExpressCT™
Embeds expression biomarkers alongside planned or ongoing studies using the same sequencing data or a custom cfDNA panel.
GenomicsNext™ custom cfDNA panel
A custom cfDNA panel designed to maximize fragmentomic signals for use with ExpressCT™.
Tissue RNA algorithm pipeline
RNA-expression-based tissue signatures for therapy selection and prognosis across six cancer types.
PurIST® pancreatic cancer test
Commercially available test that uses RNA sequencing information to classify PDAC into basal or classical subtype.
PurIST® Liquid
Applies ExpressCT™ fragmentomics to cfDNA sequencing to call classical versus basal-like PDAC subtype from blood.
3 more services
- ExpressCT™
- GenomicsNext™
- PurIST®
- What to send
- FASTQ files from a banked CGP or WGS cohort
- a blood draw alone
- Sequencing data
- Custom cfDNA panel data
Capabilities
- Assays and studies
- NGS
- Gene expression profiling
- Liquid biopsy
- cfDNA sequencing
- RNA sequencing
- WGS
8 more
- WES
- FASTQ analysis
- Molecular subtyping
- Tumor fraction
- Tissue of origin
- RNA expression profiling
- Fragmentomics
- Gene expression biomarker analysis
- Therapeutic areas
- Precision oncology
- Breast cancer
- Pancreatic cancer
- Lung cancer
- Solid tumors
Modalities and species
- Modalities
- ADC
- Cell therapy
- Species and models
- PDAC
- Breast cancer
- Lung cancer
Industries served
- Biopharma
- Diagnostics
- Technology
- CRO
- Commercial labs
Details
- Founded
- 2005
- Ownership
- Small business, as registered with SAM.gov or stated on their site
- Address
- 6 Davis Dr. Suite 146 Durham, NC 27709
- Phone
- (919) 973-6544